Quest Diagnostics (DGX) Cost of Revenue (2009 - 2026)

Quest Diagnostics has disclosed Cost of Revenue across 18 years of filings, most recently posting $2.0 billion for Q2 2026.

• In Q2 2026, Cost of Revenue rose 10.89% year-over-year to $2.0 billion; the TTM figure through Jun 2026 stood at $7.7 billion (up 9.72% YoY), while the FY2025 annual figure was $7.4 billion, up 11.19% from the prior year.
• Cost of Revenue came in at $2.0 billion for Q2 2026 at Quest Diagnostics, up from $2.0 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.0 billion in Q2 2026 to a low of $1.5 billion in Q3 2023.
• Average Cost of Revenue over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2022.
• Year-over-year, Cost of Revenue retreated 8.32% in 2022 and rose 14.12% in 2025.
• Over 5 years, Cost of Revenue stood at $1.6 billion in 2022, then slipped by 1.46% to $1.6 billion in 2023, then rose by 13.6% to $1.8 billion in 2024, then rose by 7.54% to $1.9 billion in 2025, then climbed by 6.33% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $2.0 billion in Q2 2026, $2.0 billion in Q1 2026, and $1.9 billion in Q4 2025.